See more : XPO Logistics, Inc. (0M1O.L) Income Statement Analysis – Financial Results
Complete financial analysis of The Pennant Group, Inc. (PNTG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Pennant Group, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Cielo Waste Solutions Corp. (CMC.V) Income Statement Analysis – Financial Results
- Diamant Art Corp. (DIAAF) Income Statement Analysis – Financial Results
- Sappi Limited (SPPJY) Income Statement Analysis – Financial Results
- MIRA Pharmaceuticals, Inc. (MIRA) Income Statement Analysis – Financial Results
- Public Power Corporation S.A. (PUPOF) Income Statement Analysis – Financial Results
The Pennant Group, Inc. (PNTG)
About The Pennant Group, Inc.
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support. As of December 31, 2021, the company operated 88 home health and hospice agencies, and 54 senior living communities with 4127 Senior Living units in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|---|
Revenue | 544.89M | 473.24M | 439.69M | 390.95M | 338.53M | 286.06M | 250.99M | 217.23M |
Cost of Revenue | 477.86M | 414.66M | 393.96M | 336.07M | 293.92M | 243.62M | 218.58M | 188.94M |
Gross Profit | 67.04M | 58.59M | 45.74M | 54.89M | 44.62M | 42.44M | 32.41M | 28.29M |
Gross Profit Ratio | 12.30% | 12.38% | 10.40% | 14.04% | 13.18% | 14.84% | 12.91% | 13.02% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 36.67M | 33.98M | 36.26M | 31.30M | 35.14M | 18.84M | 14.46M | 12.45M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 36.67M | 33.98M | 36.26M | 31.30M | 35.14M | 18.84M | 14.46M | 12.45M |
Other Expenses | 0.00 | 4.90M | 4.78M | 4.68M | 3.81M | 2.96M | 2.54M | 2.86M |
Operating Expenses | 41.87M | 38.88M | 41.04M | 35.97M | 38.95M | 21.81M | 17.01M | 15.30M |
Cost & Expenses | 519.72M | 453.54M | 435.00M | 372.04M | 332.86M | 265.43M | 235.59M | 204.24M |
Interest Income | 0.00 | 3.82M | 1.94M | 1.24M | 410.00K | 0.00 | 0.00 | 0.00 |
Interest Expense | 5.92M | 3.82M | 1.94M | 1.24M | 410.00K | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 5.13M | 4.90M | 4.78M | 4.68M | 4.03M | 2.96M | 2.54M | 2.86M |
EBITDA | 30.64M | 24.60M | 9.46M | 23.82M | 9.48M | 23.60M | 17.95M | 15.84M |
EBITDA Ratio | 5.62% | 5.19% | 2.15% | 6.09% | 2.80% | 8.25% | 7.15% | 7.29% |
Operating Income | 25.17M | 19.67M | 4.70M | 18.92M | 5.67M | 20.63M | 15.40M | 12.98M |
Operating Income Ratio | 4.62% | 4.16% | 1.07% | 4.84% | 1.67% | 7.21% | 6.14% | 5.98% |
Total Other Income/Expenses | -5.59M | -3.85M | -1.97M | -1.01M | -410.00K | 0.00 | 0.00 | 0.00 |
Income Before Tax | 19.58M | 8.89M | 2.73M | 17.90M | 5.26M | 20.63M | 15.40M | 12.98M |
Income Before Tax Ratio | 3.59% | 1.88% | 0.62% | 4.58% | 1.55% | 7.21% | 6.14% | 5.98% |
Income Tax Expense | 5.67M | 1.65M | 582.00K | 2.35M | 2.09M | 4.35M | 5.38M | 5.07M |
Net Income | 13.38M | 6.64M | 2.15M | 15.74M | 2.55M | 15.68M | 9.87M | 7.89M |
Net Income Ratio | 2.46% | 1.40% | 0.49% | 4.03% | 0.75% | 5.48% | 3.93% | 3.63% |
EPS | 0.45 | 0.23 | 0.08 | 0.56 | 0.09 | 0.56 | 0.35 | 0.28 |
EPS Diluted | 0.44 | 0.22 | 0.07 | 0.52 | 0.09 | 0.56 | 0.35 | 0.28 |
Weighted Avg Shares Out | 29.86M | 29.06M | 28.41M | 28.03M | 27.84M | 27.83M | 27.83M | 28.00M |
Weighted Avg Shares Out (Dil) | 30.19M | 30.16M | 30.64M | 30.23M | 29.59M | 28.00M | 28.00M | 28.00M |
Here is Why Growth Investors Should Buy The Pennant Group (PNTG) Now
The Pennant Group Announces Public Offering of Common Stock
3 Reasons Why Growth Investors Shouldn't Overlook The Pennant Group (PNTG)
Is The Pennant Group (PNTG) a Solid Growth Stock? 3 Reasons to Think "Yes"
The Pennant Group (PNTG) is an Incredible Growth Stock: 3 Reasons Why
3 Ways to Play the Long-Term Care Crisis in 2024
Here's What Key Metrics Tell Us About The Pennant Group (PNTG) Q2 Earnings
The Pennant Group, Inc. (PNTG) Tops Q2 Earnings and Revenue Estimates
Pennant Completes Acquisition of Signature Healthcare at Home's Washington and Idaho Assets
The Pennant Group Announces New $250 Million Credit Facility
Source: https://incomestatements.info
Category: Stock Reports